Elaine J. Heron's most recent trade in Vaxart Inc was a trade of 95,400 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 13, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Vaxart Inc | Elaine J. Heron | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2025 | 95,400 | 95,400 | - | - | Stock Option (right to buy) | |
| Vaxart Inc | Elaine J. Heron | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2025 | 16,000 | 56,566 (0%) | 0% | 0 | Common Stock | |
| Palvella Therapeutics Inc. | Elaine J. Heron | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 12,350 | 12,350 | - | - | Non-Qualified Stock Option (right to buy) | |
| Palvella Therapeutics Inc. | Elaine J. Heron | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2024 | 24,700 | 24,700 | - | - | Stock Option (right to buy) | |
| Vaxart Inc | Elaine J. Heron | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 95,400 | 95,400 | - | - | Stock Option (right to buy) | |
| Vaxart Inc | Elaine J. Heron | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 16,000 | 40,566 (0%) | 0% | 0 | Common Stock | |
| Biomarin Pharmaceutical Inc | Elaine J. Heron | Director | 03 Jun 2024 | 5,047 | 101,888 (0%) | 0% | 63.1 | 318,466 | Common Stock | |
| Biomarin Pharmaceutical Inc | Elaine J. Heron | Director | 03 Jun 2024 | 5,047 | 0 | - | - | Stock Option (Right to Buy Common Stock) | ||
| Biomarin Pharmaceutical Inc | Elaine J. Heron | Director | 03 Jun 2024 | 4,168 | 97,720 (0%) | 0% | 76.4 | 318,477 | Common Stock | |
| Biomarin Pharmaceutical Inc | Elaine J. Heron | Director | 21 May 2024 | 4,720 | 96,841 (0%) | 0% | 0 | Common Stock | ||
| Vaxart Inc | Elaine J. Heron | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2023 | 41,510 | 41,510 | - | - | Stock Option (right to buy) | |
| Vaxart Inc | Elaine J. Heron | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2023 | 6,922 | 24,566 (0%) | 0% | 0 | Common Stock | |
| Biomarin Pharmaceutical Inc | Elaine J. Heron | Director | 23 May 2023 | 4,190 | 92,121 (0%) | 0% | 0 | Common Stock | ||
| Biomarin Pharmaceutical Inc | Elaine J. Heron | Director | 12 May 2023 | 8,500 | 94,068 (0%) | 0% | 67.8 | 576,385 | Common Stock | |
| Biomarin Pharmaceutical Inc | Elaine J. Heron | Director | 12 May 2023 | 8,500 | 0 | - | - | Stock Option (Right to Buy Common Stock) | ||
| Biomarin Pharmaceutical Inc | Elaine J. Heron | Director | 12 May 2023 | 6,137 | 87,931 (0%) | 0% | 93.9 | 576,448 | Common Stock | |
| Vaxart Inc | Elaine J. Heron | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Aug 2022 | 88,448 | 88,448 | - | - | Stock Option (right to buy) | |
| Vaxart Inc | Elaine J. Heron | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Aug 2022 | 14,750 | 17,644 (0%) | 0% | 0 | Common Stock | |
| Biomarin Pharmaceutical Inc | Elaine J. Heron | Director | 24 May 2022 | 4,980 | 85,568 (0%) | 0% | 0 | Common Stock | ||
| Biomarin Pharmaceutical Inc | Elaine J. Heron | Director | 25 Feb 2022 | 8,500 | 0 | - | - | Stock Option (Right to buy Common Stock) | ||
| Biomarin Pharmaceutical Inc | Elaine J. Heron | Director | 25 Feb 2022 | 8,500 | 80,588 (0%) | 0% | 37.5 | 318,410 | Common Stock | |
| Biomarin Pharmaceutical Inc | Elaine J. Heron | Director | 25 May 2021 | 5,120 | 72,088 (0%) | 0% | 0 | Common Stock | ||
| Biomarin Pharmaceutical Inc | Elaine J. Heron | Director | 07 Oct 2020 | 15,000 | 0 | - | - | Stock Option (Right to buy Common Stock) | ||
| Biomarin Pharmaceutical Inc | Elaine J. Heron | Director | 07 Oct 2020 | 15,000 | 66,968 (0%) | 0% | 26.5 | 397,350 | Common Stock |